Actinium Pharmaceuticals, Inc.
ATNM· NYSE
ATNMActinium Pharmaceuticals, Inc.
Filed Aug 4, 2017 · 10-Q · 35 days after period end · 0001213900-17-008244
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Net Income | -$7.05M | -$6.62M | -$7.46M | $3.52M |
| EPS Diluted | -$0.12 | -$0.15 | -$0.20 | $0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Actinium Pharmaceuticals, Inc. · CIK 1388320 · Engraved from SEC EDGAR
ended Jun 30, 2017 · filed Aug 4, 2017 · 35 d after period end
